ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1626203
This article is part of the Research TopicDigital Technology in the Management and Prevention of Diabetes: Volume IIIView all articles
Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population
Provisionally accepted- 1Department of Endocrinology, The First Affiliated Hospital of Ningbo University,, ningbo, China
- 2Department of Endocrinology, Beilun District People's Hospital, ningbo, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, seriously threatening the public health. Although the proportion of patients with lean NAFLD is lower than that of patients with obese NALFD, it should not be overlooked. This study aimed to construct interpretable machine learning models for predicting lean NAFLD risk in type 2 diabetes mellitus (T2DM) patients. Methods: This study enrolled 1,553 T2DM individuals who received health care at the First Affiliated Hospital of Ningbo University, Ningbo, China, from November 2019 to November 2024. Feature screening was performed using the Boruta algorithm and the Least Absolute Shrinkage and Selection Operator (LASSO). Linear discriminant analysis (LDA), logistic regression (LR), Naive Bayes (NB), random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGboost) were used in constructing risk prediction models for lean NAFLD in T2DM patients. The area under the receiver operating characteristic curve (AUC) was used to assess the predictive capacity of the model. Additionally, we employed SHapley Additive exPlanations (SHAP) analysis to unveil the specific contributions of individual features in the machine learning model to the prediction results.Results: The prevalence of lean NAFLD in the study population was 20.3%. Eight variables, including age, body mass index (BMI), and alanine aminotransferase (ALT), were identified as independent risk factors for lean NAFLD. Ten predictive factors, including BMI, ALT, and aspartate aminotransferase (AST), were screened for the construction of risk prediction models. The random forest model demonstrated superior performance compared to alternative machine learning (ML) algorithms, achieving an AUC of 0.739 (95% confidence interval [CI]: 0.676–0.802) in the training set, and it also exhibited the best predictive value in the internal validation set with an AUC of 0.789 (95% CI: 0.722–0.856). In addition, the SHAP method identified TG, ALT, GGT, BMI, and UA as the top five variables influencing the predictions of the RF model.Conclusion: The construction of lean NAFLD risk models based on the Chinese T2DM population, particularly the RF model, facilitates its early prevention and intervention, thereby reducing the risks of intrahepatic and extrahepatic adverse outcomes.
Keywords: Lean non-alcoholic fatty liver disease, type 2 diabetes mellitus, Interpretable machine learning, Prediction model, Predict risk
Received: 10 May 2025; Accepted: 23 Jun 2025.
Copyright: © 2025 Bao, Jin, Wang, Mao and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Tieqiao Wang, Department of Endocrinology, The First Affiliated Hospital of Ningbo University,, ningbo, China
Yushan Mao, Department of Endocrinology, The First Affiliated Hospital of Ningbo University,, ningbo, China
Guoqing Huang, Department of Endocrinology, The First Affiliated Hospital of Ningbo University,, ningbo, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.